NVUS Insider Trading Activity and SEC Form 4 Filings
NVUS insider trading summary
No open-market insider purchases or sales of Novus Therapeutics, Inc. (NVUS) have been reported on SEC Form 4 in the past 12 months.
Latest NVUS insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Dec 2, 2020 | OrbiMed Israel BioFund GP Limited Partnership | 10% Owner | Sell | $2.2M (103,200 @ $21.60) |
| Dec 2, 2020 | OrbiMed Israel GP Ltd. | 10% Owner | Sell | $2.2M (103,200 @ $21.60) |
| Oct 30, 2020 | Logos Global Management LP | 10% Owner | Buy | $335K (12,942 @ $25.88) |
| Oct 30, 2020 | Logos Global Management LP | 10% Owner | Sell | $730 (27 @ $27.02) |
| Oct 30, 2020 | Logos Global Management LP | 10% Owner | Buy | $120K (5,000 @ $24.03) |
| Oct 30, 2020 | Logos Global Management LP | 10% Owner | Sell | $345K (12,942 @ $26.64) |
| Oct 30, 2020 | Logos Global Management LP | 10% Owner | Buy | $760K (31,000 @ $24.53) |
| Oct 30, 2020 | Logos Global Management LP | 10% Owner | Buy | $104K (4,000 @ $25.97) |
| Oct 30, 2020 | Logos Global Management LP | 10% Owner | Buy | $393K (15,000 @ $26.17) |
| Oct 30, 2020 | Logos Global Management LP | 10% Owner | Buy | $397K (15,000 @ $26.48) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.